SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibodies Share News (FAB)

Share Price Information for Fusion Antibodies (FAB)

Share Price is delayed by 15 minutes
Get Live Data
12.00    -0.25 (-2.04%)
Bid:
11.50
Ask:
12.50
Spread: 1.00 (8.696%)
Market Cap: £15.02m
FAB Live PriceLast checked at - London Stock Exchange

Intraday Fusion Antibodies Share Chart

Fusion Antibodies News

Omega Diagnostics Signs Contract To Make Covid Tests; Appoints Chair
11 Feb 2021

Omega Diagnostics Signs Contract To Make Covid Tests; Appoints Chair

Omega Diagnostics Signs Contract To Make Covid Tests; Appoints Chair

Fusion Antibodies Half-Year Revenue Rises And Loss Narrows
20 Nov 2020

Fusion Antibodies Half-Year Revenue Rises And Loss Narrows

Fusion Antibodies Half-Year Revenue Rises And Loss Narrows

UK Earnings, Trading Statements Calendar - Next 7 Days
13 Nov 2020

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

IN BRIEF: Fusion Antibodies Gets Grant From Invest Northern Ireland
27 Oct 2020

IN BRIEF: Fusion Antibodies Gets Grant From Invest Northern Ireland

IN BRIEF: Fusion Antibodies Gets Grant From Invest Northern Ireland

UK DIRECTOR DEALINGS SUMMARY: Supply@Me CEO Buys GBP1 Million Option
24 Sep 2020

UK DIRECTOR DEALINGS SUMMARY: Supply@Me CEO Buys GBP1 Million Option

UK DIRECTOR DEALINGS SUMMARY: Supply@Me CEO Buys GBP1 Million Option

IN BRIEF: Fusion Antibodies Surges On Virus Study Progress
18 Sep 2020

IN BRIEF: Fusion Antibodies Surges On Virus Study Progress

IN BRIEF: Fusion Antibodies Surges On Virus Study Progress

UK Shareholder Meetings Calendar - Next 7 Days
18 Sep 2020

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Fusion Antibodies soars on Covid-19 test progress
18 Sep 2020

Fusion Antibodies soars on Covid-19 test progress

(Sharecast News) - Fusion Antibodies shares soared after the antibody specialist said it had made progress on developing coronavirus antigen tests.